PROGRAM TABLETS 409.8MG DIN 02087367
Health Canada record
| Active ingredient(s) | LUFENURON 409.8 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1994 |
| Current status date | 22-Jun-2000 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LUFENURON
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02238928 | PROGRAM | ELANCO CANADA LIMITED | Tablet | LUFENURON 90 MG | Cancelled Post Market |
| 02238927 | PROGRAM | NOVARTIS ANIMAL HEALTH CANADA INC | Tablet | LUFENURON 45 MG | Cancelled Post Market |
| 02238926 | PROGRAM | ELANCO CANADA LIMITED | Tablet | LUFENURON 409.8 MG | Cancelled Post Market |
| 02238925 | PROGRAM | ELANCO CANADA LIMITED | Tablet | LUFENURON 204.9 MG | Cancelled Post Market |
| 02237517 | PROGRAM 40 | ELANCO CANADA LIMITED | Suspension | LUFENURON 40 MG | Cancelled Post Market |
| 02237516 | PROGRAM 80 | ELANCO CANADA LIMITED | Suspension | LUFENURON 80 MG | Cancelled Post Market |
| 02057832 | PROGRAM SUSPENSION | ELANCO CANADA LIMITED | Suspension | LUFENURON 133 MG | Cancelled Post Market |
| 02192632 | PROGRAM SUSPENSION | ELANCO CANADA LIMITED | Suspension | LUFENURON 266 MG | Cancelled Post Market |
| 02087359 | PROGRAM TABLETS 204.9MG | NOVARTIS ANIMAL HEALTH CANADA INC | Tablet | LUFENURON 204.9 MG | Cancelled Post Market |
| 02087332 | PROGRAM TABLETS 45MG | NOVARTIS ANIMAL HEALTH CANADA INC | Tablet | LUFENURON 45 MG | Cancelled Post Market |
| 02087340 | PROGRAM TABLETS 90MG | NOVARTIS ANIMAL HEALTH CANADA INC | Tablet | LUFENURON 90 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 6795 | 1997-09-05 | New Drug Submission (NDS) | |
| 7492 | 1994-04-19 | New Drug Submission (NDS) |